Shopping Cart 0
Cart Subtotal
AED 0

Active Pharmaceutical Ingredients Market in India 2017

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 3487

Details

Netscribes' latest market research report titled Active Pharmaceutical Ingredients Market in India 2017 states that manufacturers of Active pharmaceutical ingredients are experiencing demand for their products due to several reasons. With the increasing prevalence of cancer amongst Indians, the health issues faced due to the lifestyle changes and age related disorders, demand for Active pharmaceutical ingredients are rapidly increasing. Advancements in technology have resulted in high production at low cost, boosting the growth. The imported products are mainly from China and these are low in cost compared to other countries.

However, despite increasing competition in the market, threat from exported products, and lack of uniformity in the market, it is still expected to grow in the coming years. Stringent regulations and environmental hazards are also posing as threats to the industry. Despite these hindrances in the industry, the market is expected to grow, with more players entering the market and government taking actions to keep the situation under control and lessen the challenges.

Coverage:

Overview of the active pharmaceutical ingredients market in India and forecasted market size data in terms of value over 2013 to 2020

Trade analysis of active pharmaceutical ingredients market in India

Qualitative analysis of the major drivers and challenges affecting the market

Analysis of the competitive landscape and profiles of major players operating in the market

Key recent developments associated with active pharmaceutical ingredients market in India

Why Buy?

Get a broad understanding of the active pharmaceutical ingredients market in India, the dynamics of the market and current state of the sector

Strategize marketing, market-entry, market expansion and other business plans by understanding the factors driving the growth of the market

Be informed regarding the key developments in the field of active pharmaceutical ingredients

Understand major competitors' business, market dynamics and respond accordingly

READ MORE

Table Of Content

Scope

Slide 1: Executive Summary

Socioeconomic Indicators

Slide 2: Total Population (2010-2011 -2019-2020), Population Density (2010-2011 -2019-2020)

Slide 3: Sex Ratio (2005, 2010, 2015, 2020), Population by Age Group (2005, 2010, 2015, 2020), Urbanization Trend (2010-2011 -2019-2020)

Slide 4: Total Fertility Rate (2005-2010, 2010-2015, 2015-2020), Infant Mortality Rate (2005-2010, 2010-2015, 2015-2020), Total Number of Births (2005-2010, 2010-2015, 2015-2020), Total Number of Death (2005-2010, 2010-2015, 2015-2020)

Slide 5: Total Literacy Rate (2001, 2011), Rural Literacy (2001, 2011), Urban Literacy (2001, 2011)

Slide 6: GDP at Market Prices (2010-2014), FDI (2010-2014), Inflation Rate (2010-2014), Unemployment Rate (2010-2014)

Slide 7: Access to Safe Drinking Water (2001, 2011), Exchange Rate (2010-2015)

Market Overview

Slide 8: Market Definition and Structure

Slide 9: Active Pharmaceutical Ingredients -Market Overview, Size and Growth (Value-Wise; FY 2013-FY 2020)

Trade Analysis

Slide 11: Export of Antibiotics -Size {Value-Wise; FY 2012-FY 2016-2017 (Apr-Sep)}, Region-Wise Exports {Value-Wise: FY 2015 and FY 2016-2017(Apr-Sep)}

Slide 12: Export of Other Organic Compounds -Size {Value-Wise; FY 2012-FY 2016-2017 (Apr-Sep)}, Region-Wise Exports {Value-Wise: FY 2015 and FY 2016-2017(Apr-Sep)}

Slide 13: Import of Antibiotics -Size {Value-Wise; FY 2012-FY 2016-2017 (Apr-Sep)}, Region-Wise Exports {Value-Wise: FY 2015 and FY 2016-2017(Apr-Sep)}

Slide 14: Import of Other Organic Compounds -Size {Value-Wise; FY 2012-FY 2016-2017 (Apr-Sep)}, Region-Wise Exports {Value-Wise: FY 2015 and FY 2016-2017(Apr-Sep)}

Market Influencers

Slide 15: Market Drivers

Slide 16: Market Challenges

Competitive Landscape

Slide 17: List of Major Players

Slide 18-47: Profiles of Major Players

Recent Developments

Slide 28: Key Recent Developments

Appendix

Slide 29: Research Methodology


List Of Figure

Socioeconomic Indicators

1. Total Population and Population Density (2010-2011 -2019-2020)

2. Sex Ratio (2005, 2010, 2015, 2020)

3. Population by Age Group (2005, 2010, 2015, 2020)

4. Urbanization Trend (2010-2011 -2019-2020)

5. Total Fertility Rate (2005-2010, 2010-2015, 2015-2020)

6. Infant Mortality Rate (2005-2010, 2010-2015, 2015-2020)

7. Total number of Births (2005-2010, 2010-2015, 2015-2020)

8. Total number of Death (2005-2010, 2010-2015, 2015-2020)

9. Total Literacy Rate (2001, 2011)

10. Rural Literacy (2001, 2011)

11. Urban Literacy (2001, 2011)

12. GDP at Market Prices (2010-2014)

13. FDI (2010-2014)

14. Inflation Rate (2010-2014)

15. Unemployment Rate (2010-2014)

16. Access to safe drinking water (2001, 2011)

17. Exchange Rate (2010-2015)

Market Overview

1. Active Pharmaceutical Ingredients -Market Size & Growth (Value-Wise; FY 2013 -FY 2020e)

Trade Analysis

1. Export of Antibiotics {Value-Wise; FY 2012-FY 2016-2017 (Apr-Sep)}

2. Region Wise Exports of Antibiotics (Value-Wise: FY 2015)

3. Region Wise Exports of Antibiotics {Value-Wise: FY 2016-2017( Apr-Sep)}

4. Export of Other Organic Compounds {Value-Wise; FY 2012-FY 2016-2017 (Apr-Sep)}

5. Region Wise Exports of Other Organic Compounds (Value-Wise: FY 2015)

6. Region Wise Exports of Other Organic Compounds {Value-Wise: FY 2016-2017( Apr-Sep)}

7. Import of Antibiotics {Value-Wise; FY 2012-FY 2016-2017 (Apr-Sep)}

8. Region Wise Imports of Antibiotics (Value-Wise: FY 2015)

9. Region Wise Imports of Antibiotics {Value-Wise: FY 2016-2017( Apr-Sep)}

10. Import of Other Organic Compounds {Value-Wise; FY 2012-FY 2016-2017 (Apr-Sep)}

11. Region Wise Imports of Other Organic Compounds (Value-Wise: FY 2015)

12. Region Wise Imports of Other Organic Compounds {Value-Wise: FY 2016-2017( Apr-Sep)}

Competitive Landscape

1. Company Profiles

a. Financial Snapshot (Only Public Companies)

b. Key Business segments (Only Public Companies)

c. Key Geographic segments (Only Public Companies)


List Of Table

Competitive Landscape

1. List of Major Players

Licence Rights

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

Public Companies

1. Abbott India Limited

2. Alkem Laboratories Limited

3. Aurobindo Pharma Limited

4. Cadila Healthcare Limited

5. Cipla Limited

6. Dr. Reddy's Laboratories Limited

7. Novartis India Limited

8. Pfizer Limited

9. Sun Pharmaceutical Industries Limited

10. Torrent Pharmaceuticals Limited

Company Profile

Company Profile Title

Netscribes' latest market research report titled Active Pharmaceutical Ingredients Market in India 2017 states that manufacturers of Active pharmaceutical ingredients are experiencing demand for their products due to several reasons. With the increasing prevalence of cancer amongst Indians, the health issues faced due to the lifestyle changes and age related disorders, demand for Active pharmaceutical ingredients are rapidly increasing. Advancements in technology have resulted in high production at low cost, boosting the growth. The imported products are mainly from China and these are low in cost compared to other countries.

However, despite increasing competition in the market, threat from exported products, and lack of uniformity in the market, it is still expected to grow in the coming years. Stringent regulations and environmental hazards are also posing as threats to the industry. Despite these hindrances in the industry, the market is expected to grow, with more players entering the market and government taking actions to keep the situation under control and lessen the challenges.

Coverage:

Overview of the active pharmaceutical ingredients market in India and forecasted market size data in terms of value over 2013 to 2020

Trade analysis of active pharmaceutical ingredients market in India

Qualitative analysis of the major drivers and challenges affecting the market

Analysis of the competitive landscape and profiles of major players operating in the market

Key recent developments associated with active pharmaceutical ingredients market in India

Why Buy?

Get a broad understanding of the active pharmaceutical ingredients market in India, the dynamics of the market and current state of the sector

Strategize marketing, market-entry, market expansion and other business plans by understanding the factors driving the growth of the market

Be informed regarding the key developments in the field of active pharmaceutical ingredients

Understand major competitors' business, market dynamics and respond accordingly

READ MORE

Scope

Slide 1: Executive Summary

Socioeconomic Indicators

Slide 2: Total Population (2010-2011 -2019-2020), Population Density (2010-2011 -2019-2020)

Slide 3: Sex Ratio (2005, 2010, 2015, 2020), Population by Age Group (2005, 2010, 2015, 2020), Urbanization Trend (2010-2011 -2019-2020)

Slide 4: Total Fertility Rate (2005-2010, 2010-2015, 2015-2020), Infant Mortality Rate (2005-2010, 2010-2015, 2015-2020), Total Number of Births (2005-2010, 2010-2015, 2015-2020), Total Number of Death (2005-2010, 2010-2015, 2015-2020)

Slide 5: Total Literacy Rate (2001, 2011), Rural Literacy (2001, 2011), Urban Literacy (2001, 2011)

Slide 6: GDP at Market Prices (2010-2014), FDI (2010-2014), Inflation Rate (2010-2014), Unemployment Rate (2010-2014)

Slide 7: Access to Safe Drinking Water (2001, 2011), Exchange Rate (2010-2015)

Market Overview

Slide 8: Market Definition and Structure

Slide 9: Active Pharmaceutical Ingredients -Market Overview, Size and Growth (Value-Wise; FY 2013-FY 2020)

Trade Analysis

Slide 11: Export of Antibiotics -Size {Value-Wise; FY 2012-FY 2016-2017 (Apr-Sep)}, Region-Wise Exports {Value-Wise: FY 2015 and FY 2016-2017(Apr-Sep)}

Slide 12: Export of Other Organic Compounds -Size {Value-Wise; FY 2012-FY 2016-2017 (Apr-Sep)}, Region-Wise Exports {Value-Wise: FY 2015 and FY 2016-2017(Apr-Sep)}

Slide 13: Import of Antibiotics -Size {Value-Wise; FY 2012-FY 2016-2017 (Apr-Sep)}, Region-Wise Exports {Value-Wise: FY 2015 and FY 2016-2017(Apr-Sep)}

Slide 14: Import of Other Organic Compounds -Size {Value-Wise; FY 2012-FY 2016-2017 (Apr-Sep)}, Region-Wise Exports {Value-Wise: FY 2015 and FY 2016-2017(Apr-Sep)}

Market Influencers

Slide 15: Market Drivers

Slide 16: Market Challenges

Competitive Landscape

Slide 17: List of Major Players

Slide 18-47: Profiles of Major Players

Recent Developments

Slide 28: Key Recent Developments

Appendix

Slide 29: Research Methodology


List Of Figure

Socioeconomic Indicators

1. Total Population and Population Density (2010-2011 -2019-2020)

2. Sex Ratio (2005, 2010, 2015, 2020)

3. Population by Age Group (2005, 2010, 2015, 2020)

4. Urbanization Trend (2010-2011 -2019-2020)

5. Total Fertility Rate (2005-2010, 2010-2015, 2015-2020)

6. Infant Mortality Rate (2005-2010, 2010-2015, 2015-2020)

7. Total number of Births (2005-2010, 2010-2015, 2015-2020)

8. Total number of Death (2005-2010, 2010-2015, 2015-2020)

9. Total Literacy Rate (2001, 2011)

10. Rural Literacy (2001, 2011)

11. Urban Literacy (2001, 2011)

12. GDP at Market Prices (2010-2014)

13. FDI (2010-2014)

14. Inflation Rate (2010-2014)

15. Unemployment Rate (2010-2014)

16. Access to safe drinking water (2001, 2011)

17. Exchange Rate (2010-2015)

Market Overview

1. Active Pharmaceutical Ingredients -Market Size & Growth (Value-Wise; FY 2013 -FY 2020e)

Trade Analysis

1. Export of Antibiotics {Value-Wise; FY 2012-FY 2016-2017 (Apr-Sep)}

2. Region Wise Exports of Antibiotics (Value-Wise: FY 2015)

3. Region Wise Exports of Antibiotics {Value-Wise: FY 2016-2017( Apr-Sep)}

4. Export of Other Organic Compounds {Value-Wise; FY 2012-FY 2016-2017 (Apr-Sep)}

5. Region Wise Exports of Other Organic Compounds (Value-Wise: FY 2015)

6. Region Wise Exports of Other Organic Compounds {Value-Wise: FY 2016-2017( Apr-Sep)}

7. Import of Antibiotics {Value-Wise; FY 2012-FY 2016-2017 (Apr-Sep)}

8. Region Wise Imports of Antibiotics (Value-Wise: FY 2015)

9. Region Wise Imports of Antibiotics {Value-Wise: FY 2016-2017( Apr-Sep)}

10. Import of Other Organic Compounds {Value-Wise; FY 2012-FY 2016-2017 (Apr-Sep)}

11. Region Wise Imports of Other Organic Compounds (Value-Wise: FY 2015)

12. Region Wise Imports of Other Organic Compounds {Value-Wise: FY 2016-2017( Apr-Sep)}

Competitive Landscape

1. Company Profiles

a. Financial Snapshot (Only Public Companies)

b. Key Business segments (Only Public Companies)

c. Key Geographic segments (Only Public Companies)


List Of Table

Competitive Landscape

1. List of Major Players

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

Public Companies

1. Abbott India Limited

2. Alkem Laboratories Limited

3. Aurobindo Pharma Limited

4. Cadila Healthcare Limited

5. Cipla Limited

6. Dr. Reddy's Laboratories Limited

7. Novartis India Limited

8. Pfizer Limited

9. Sun Pharmaceutical Industries Limited

10. Torrent Pharmaceuticals Limited